Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress

Rukhsana Sultana, D. Allan Butterfield

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disease. AD is characterized by the presence of senile plaques, neurofibrillary tangles, and synaptic loss. Amyloid β-peptide (Aβ), a component of senile plaques, has been proposed to play an important role in oxidative stress in AD brain and could be one of the key factors in the pathogenesis of AD. In the present review, we discuss some of the AD animal models that express Aβ, and compare the proteomics-identified oxidatively modified proteins between AD brain and those of Aβ models. Such a comparison would allow better understanding of the role of Aβ in AD pathogenesis thereby helping in developing potential therapeutics to treat or delay AD.

Original languageEnglish
Pages (from-to)685-696
Number of pages12
JournalProteomics - Clinical Applications
Volume2
Issue number5
DOIs
StatePublished - May 2008

Keywords

  • Alzheimer's disease
  • AmyIoid beta-peptide
  • Caenorhabditis elegans
  • Canine
  • Oxidative stress

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress'. Together they form a unique fingerprint.

Cite this